Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bolus recombinant urokinase versus heparin in deep venous thrombosis: a randomized controlled trial.

Bolus recombinant urokinase versus heparin in deep venous thrombosis: a randomized controlled trial. Am Heart J. 1996 Aug; 132(2 Pt 1):314-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.